Highline Wealth Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEZ
PCM
RCM
WAM
Highline Wealth Partners's BMEZ Position: Q4 2025 in Review
Highline Wealth Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2025, closing a stake of 150 shares — an estimated $2.16K sold.
Highline Wealth Partners first reported a position in BMEZ in Q3 2025 and held it in 1 quarter. The position peaked at $2.16K in Q3 2025. 86 funds tracked by Wall St. Rank hold BMEZ as of Q4 2025.
- Highline Wealth Partners reported no remaining BlackRock Health Sciences Trust II position as of Q4 2025 after selling out during the quarter.
- Highline Wealth Partners sold 150 BlackRock Health Sciences Trust II shares in Q4 2025, an estimated $2.16K.
- Highline Wealth Partners first reported a position in BlackRock Health Sciences Trust II in Q3 2025 and held it in 1 quarter.
- Highline Wealth Partners's BlackRock Health Sciences Trust II position peaked at $2.16K in Q3 2025.
- 86 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2025.
Based on Highline Wealth Partners's 13F filing for Q4 2025, filed 15 Jan 2026.